View drug registration information details.
| Items | Registration information |
|---|
| ID | 318 |
|---|
| No | 318 |
|---|
| Brand Name | HOVASC 5 MG |
|---|
| Ingredients | AMLODIPINE BESILATE 5 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 10 TABLETS/BLISTER, 100 TABLETS/BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AMLODIPINE IS INDICATED FOR THE FIRST LINE TREATMENT OF HYPERTENSION AND CAN BE USED AS THE SOLE AGENT TO CONTROL BLOOD PRESSURE IN THE MAJORITY OF PATIENTS NOT ADEQUATELY CONTROLLED ON A SINGLE ANTIHYPERTENSIVE AGENT MAY BENEFIT FROM THE ADDITION OF AMLO |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | OBLONG, WHITE TO OFF WHITE UNCOATED TABLET, BEVEL EDGED, SHALLOW CONVEX WITH BREAK BAR ON ONE FACE AND "HOVID"EMBOSSED ON ANOTHER FACE. |
|---|
| Note | |
|---|
| License Owner | BMS PHARMA SOLE CO.,LTD |
|---|
| Manufacturer | HOVID BHD |
|---|
| Country | MALAYSIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 I 4167/16 |
|---|
| FDD Registration Date | 07-JUN-2023 |
|---|
| Expiry Date | 06-JUN-2026 |
|---|
Back to drug list
|
